CALR and neoplasm: In this model, anthracyclins induced the translocation of calreticulin (CRT) to the cell surface, and CRT was exposed by dying tumor cells phagocytosed by DCs, resulting in the presentation of tumor antigens and the induction of immunogenicity in tumor cells (5,6).